- Home
- QURE vs REAL Comparison
QURE vs REAL Comparison
Compare QURE & REAL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QURE
- REAL
- Stock Information
- Founded
- QURE 1998
- REAL 2011
- Country
- QURE Netherlands
- REAL United States
- Employees
- QURE N/A
- REAL N/A
- Industry
- QURE Biotechnology: Pharmaceutical Preparations
- REAL Other Specialty Stores
- Sector
- QURE Health Care
- REAL Consumer Discretionary
- Exchange
- QURE Nasdaq
- REAL Nasdaq
- Market Cap
- QURE 866.3M
- REAL 871.2M
- IPO Year
- QURE 2007
- REAL 2019
- Fundamental
- Price
- QURE $14.16
- REAL $10.45
- Analyst Decision
- QURE Strong Buy
- REAL Strong Buy
- Analyst Count
- QURE 11
- REAL 5
- Target Price
- QURE $39.91
- REAL $11.70
- AVG Volume (30 Days)
- QURE 1.1M
- REAL 4.3M
- Earning Date
- QURE 11-04-2025
- REAL 11-03-2025
- Dividend Yield
- QURE N/A
- REAL N/A
- EPS Growth
- QURE N/A
- REAL N/A
- EPS
- QURE N/A
- REAL N/A
- Revenue
- QURE $14,337,000.00
- REAL $636,971,000.00
- Revenue This Year
- QURE N/A
- REAL $14.27
- Revenue Next Year
- QURE $288.08
- REAL $9.94
- P/E Ratio
- QURE N/A
- REAL N/A
- Revenue Growth
- QURE N/A
- REAL 12.68
- 52 Week Low
- QURE $4.45
- REAL $2.71
- 52 Week High
- QURE $19.18
- REAL $11.38
- Technical
- Relative Strength Index (RSI)
- QURE 34.28
- REAL 79.68
- Support Level
- QURE $17.03
- REAL $8.02
- Resistance Level
- QURE $17.76
- REAL $10.35
- Average True Range (ATR)
- QURE 0.95
- REAL 0.49
- MACD
- QURE -0.39
- REAL 0.16
- Stochastic Oscillator
- QURE 3.13
- REAL 97.98
About QURE uniQure N.V.
uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases.
About REAL The RealReal Inc.
The RealReal is the largest pure-play luxury resale platform in the US, generating $1.8 billion in 2024 gross merchandise volume and addressing a niche (personal luxury resale) that had previously been serviced by inefficient upscale boutiques and local pawn shops. The company generates revenue via consignment and first-party sales on its online marketplace, and through a small volume of direct sales. With a hands-on approach that actively sources inventory and authenticates every item on its platform, The RealReal is able to justify much higher take rates than peers, working out to roughly 36% of net merchandise value in 2024, which excludes returns, cancellations, and first-party sales.